Fundraising Fox

Humabiologics

Phoenix, US · Founded 2018 · Arizona corporation

Humabiologics is a regenerative medicine company that produces human-derived biomaterials from donated human tissues for use in regenerative medicine research and drug discovery. It supplies these biomaterials to scientists and researchers, manufacturing under FDA, ISO, and cGMP standards.

Founders & leadership

Humabiologics was founded in 2018 by Mohammad Albanna.

MAMohammad Albanna
Mohammad AlbannainFounder & CEO

Reported raises · per SEC filings

Form D private placements

$692.4K disclosed across 2 rounds · 2020–2021

$667.4KraisedJan 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mohammad AlbannaExecutive Officer, Director
  • Dan MahaffeyExecutive Officer
Offering amount
$3M
Amount sold
$667.4K
Minimum investment
$25K
First sale
Dec 2021
Incorporated
Corporation, Arizona, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$25KraisedJan 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mohammad AlbannaExecutive Officer, Director
Offering amount
$1M
Amount sold
$25K
Minimum investment
$5K
First sale
Jan 2020
Incorporated
Corporation, Arizona, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Humabiologics do?
Humabiologics is a regenerative medicine company that produces human-derived biomaterials from donated human tissues for use in regenerative medicine research and drug discovery. It supplies these biomaterials to scientists and researchers, manufacturing under FDA, ISO, and cGMP standards.
Who founded Humabiologics?
Humabiologics was founded by Mohammad Albanna in 2018.
How much funding has Humabiologics raised?
Humabiologics has disclosed $692.4K raised across 2 rounds.
Where is Humabiologics headquartered?
Humabiologics is headquartered in Phoenix, US.